/Investor DB

DCVC Bio — 2016 Investments

1 investments dated 2016 · listed companies and verified rows first · show all

Novome Biotechnologiesnovomebio.comNov 2016 · $33M

South San Francisco biotech engineering commensal gut bacteria into controllable live therapeutics for chronic diseases.

Daly City, US

Weston Whitaker(Executive Officer, Director, Promoter)William DeLoache(Director)Samuel Smits(Director)

BoardElizabeth Stanley(Director)

Co-investorsAlta PartnersCerity Partners VenturesColorcon Ventures5AM VenturesAlexandriaDCVC (Data Collective)+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.